SETALUM surgical sealant receives CE mark for commercialization in Europe

SETALUM surgical sealant, a bio-inspired surgical glue, has received CE Mark approval, clearing the path to commercialization in Europe. The technology was originally developed at MIT, Harvard Medical School, and Brigham and Women’s Hospital, but is now being commercialized by Gecko Biomedical, a biomedical start-up in France.

The glue is a surgic (Read more...)

Full Story →